Penn Medicine Presents at the 27th Annual Meeting of the American Society of Gene and Cell Therapy
Researchers from the Gene Therapy Program (GTP) at the Perelman School of Medicine at the University of Pennsylvania will present ten research abstracts, two invited talks, and a workshop presentation highlighting their translational science and discovery research on gene therapy, gene editing, and adeno-associated virus (AAV) vector technology at the American Society of Cell and Gene Therapy (ASGCT) 27th Annual Meeting on May 7 – 11, 2024 in Baltimore, Maryland.
The Penn GTP is an academic program focused on genetic medicines led by James M. Wilson, MD, PhD, the Rose H. Weiss Professor and director at the Orphan Disease Center and a professor of Medicine and Pediatrics at the Perelman School of Medicine.
The team at Penn’s GTP continues to make substantial progress in understanding AAV vector biology to support the development of successful gene therapies. In addition, they will present novel applications of a broad range of genetic medicines for rare and acquired diseases with high unmet need.